# US 2021/0070822 A1 · Method for the Purification of G-CSF

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0070822 A1
- Document ID: US20210070822A1
- Status: Published application
- Kind: A1
- Application number: 17/076,440
- Filed: 2020-10-21
- Published: 2021-03-11
- Earliest claimed: 2005-07-15
- Assignees: Mylan Pharmaceuticals Inc.
- Applicants: Mylan Pharmaceuticals Inc.
- Inventors: Arndt Dietrich; Bernhard Janowski; Jörg Schäffner; Ulrich Blaschke
- Web page: https://patentgrep.com/patent/US20210070822A1

## CPC

- C07K 14/535: Granulocyte CSF; Granulocyte-macrophage CSF
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 31/04: Antibacterial agents
- A61P 35/00: Antineoplastic agents
- A61P 37/04: Immunostimulants
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a method for obtaining recombinant granulocyte-colony stimulating factor (G-CSF), comprising at least one cation exchange chromatography and at least one hydrophobic interaction chromatography, wherein said two chromatographic steps are immediately consecutive in optional order. In particular, the present invention relates to a method for purifying G-CSF from a mixture of G-CSF and other proteins, comprising two cation exchange chromatography steps which are conducted before and after a hydrophobic interaction chromatography, respectively.

## Claims

### Claim 1

A method of purifying a protein expressed in a denatured insoluble intracellular form in a non-mammalian expression system, comprising:
(a) solubilizing the protein in a solubilization solution comprising a solubilizing agent;
(b) forming a refold solution comprising the solubilization solution and a refold buffer, the refold buffer comprising a refolding agent;
(c) loading the refold solution to a chromatography matrix under conditions for the protein to bind to the matrix;
(d) washing the chromatography matrix; and
(e) eluting the protein from the chromatography matrix.
